Upcoming webinars

Embracing scientific complexity to mitigate toxicity issues and development risks while advancing toward the clinic

April 1st, 2026 at 3:00 PM CEST / 2:00 PM BST / 9:00 AM ET

Drug discovery programs are becoming increasingly complex, and early scientific decisions play a critical role in reducing downstream risk. In this webinar, Goran Verspui, Head of Drug Development at Symeres, and James Lanter, Principal at 8D MedChem, share practical insights on how embracing molecular complexity through early CMC strategy and cross-disciplinary thinking can help identify toxicity risks sooner and support more efficient progression toward the clinic.

The Greatest Hits: A beginner’s guide to high-quality starting points for Drug Discovery

23 April 2026 at 4:00 PM CEST / 3:00 PM BST / 10:00 AM EDT

Selecting the right starting point is critical to the success of any drug discovery program. In this webinar, Sam Ceusters, Head of Chemistry at Symeres, shares practical guidance on how to identify and progress high-quality starting points, from screening library selection through to early hit evaluation.

Drawing on his expertise in medicinal chemistry and library design, Sam explores how stronger early decisions can reduce downstream risk and support more efficient progression toward development.

DILI Uncovered: how to mitigate hepatoxicity failure

6th May 2026 at 9:00 AM EDT / 2:00 PM BST / 3:00 PM CEST

Drug-induced liver injury (DILI) remains a major cause of failure in drug development, often emerging despite promising early data. In this webinar, Dr. Sanna-Mari Aatsinki, Head of Drug-Drug Interactions and In Vitro Toxicology at Admescope (a Symeres company), shares insights on how to identify and mitigate DILI risk earlier through improved in vitro models and mechanistic understanding.